Stimulation of Gastrin-CCKB Receptor Promotes Migration of Gastric AGS Cells Via Multiple Paracrine Pathways
Overview
Physiology
Authors
Affiliations
Responses to G protein-coupled receptor stimulation may be mediated by paracrine factors. We have developed a coculture system to study paracrine regulation of migration of gastric epithelial (AGS) cells after stimulation of gastrin-CCK(B) receptors. In cells expressing this receptor, G-17 stimulated migration by activation of protein kinase C. However, G-17 also stimulated the migration of cells expressing green fluorescent protein, but not the receptor, when they were cocultured with receptor-expressing cells consistent with activation of paracrine signals. The use of various pharmacological inhibitors indicated that gastrin stimulated migration via activation of the EGF receptor (EGR-R), the erbB-2 receptor tyrosine kinase, and the MAP kinase pathway. However, gastrin also released fibroblast growth factor (FGF)-1, and migration was inhibited by the FGF receptor tyrosine kinase inhibitor SU-5402. Flow cytometry indicated that in both cell types, gastrin increased MAP kinase via activation of EGF-R but not FGF-R1 or erbB-2. We conclude that gastrin-CCK(B) receptors stimulate epithelial cell migration partly via paracrine mechanisms; transactivation of EGF-R is only one component of the paracrine pathway.
Zhao Y, Wang Q, Zeng Y, Xie Y, Zhou J J Cancer. 2022; 13(1):134-145.
PMID: 34976177 PMC: 8692687. DOI: 10.7150/jca.51854.
Hong H, Kim A, Kim M, Ko H, Jung M Cancers (Basel). 2020; 12(8).
PMID: 32784492 PMC: 7463819. DOI: 10.3390/cancers12082220.
Hypergastrinemia Expands Gastric ECL Cells Through CCK2R Progenitor Cells via ERK Activation.
Sheng W, Malagola E, Nienhuser H, Zhang Z, Kim W, Zamechek L Cell Mol Gastroenterol Hepatol. 2020; 10(2):434-449.e1.
PMID: 32330731 PMC: 7371950. DOI: 10.1016/j.jcmgh.2020.04.008.
Netazepide Inhibits Expression of Pappalysin 2 in Type 1 Gastric Neuroendocrine Tumors.
Lloyd K, Parsons B, Burkitt M, Moore A, Papoutsopoulou S, Boyce M Cell Mol Gastroenterol Hepatol. 2020; 10(1):113-132.
PMID: 32004755 PMC: 7215182. DOI: 10.1016/j.jcmgh.2020.01.010.
Kumar J, Aolymat I, Tiszlavicz L, Reisz Z, Garalla H, Beynon R Oncotarget. 2019; 10(2):98-112.
PMID: 30719206 PMC: 6349446. DOI: 10.18632/oncotarget.26414.